Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues

Abstract

Bone marrow transplantation (BMT) represents a potentially curative treatment of thalassemia. For patients without an HLA-identical sibling donor, recourse to an unrelated donor is a practicable option but the candidates and their families are faced with a difficult decision. They can either choose to continue the supportive therapy, with no chance of definitive cure, or they accept the mortality risk of BMT in the hope of obtaining a definitive resolution of the disease. We investigated the communication strategies and the post transplantation quality of life (QoL) in 19 adult thalassemia patients surviving after an unrelated donor BMT. The patients were given two questionnaires: a questionnaire to evaluate pre-transplantation communication factors and the EORTC QLQ-C30 questionnaire to assess global QoL. All patients were satisfied with the communication modalities employed by the physicians. The global post transplantation QoL in our patient cohort was found to be good. The approach used in this study may offer a contribution to understanding the decision-making process leading to the choice of a treatment with a high mortality risk for a chronic, non-malignant disease. Finally, some ethical issues of this therapeutic approach are briefly addressed.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Atkin K, Ahmad W . Living a ‘normal life’: young people coping with thalassemia major or sickle cell disorder. Soc Sci Med 2001; 53: 615–626.

    Article  CAS  Google Scholar 

  2. La Nasa G, Giardini C, Argiolu F, Locatelli F, Arras M, De Stefano P et al. Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood 2002; 99: 4350–4356.

    Article  CAS  Google Scholar 

  3. La Nasa G, Caocci G, Argiolu F, Giardini C, Locatelli F, Vacca A et al. Unrelated donor bone marrow transplantation in adult patients with thalassemia. Bone Marrow Transplant 2005; 36: 971–976.

    Article  CAS  Google Scholar 

  4. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al. For the European Organization for Research and Treatment of Cancer. Study Group on Quality of Life. The EORTC QLQ-30: a quality of life instrument for use in international trials in oncology. J Natl Cancer Inst 1993; 85: 365–376.

    Article  CAS  Google Scholar 

  5. Schofield PE, Butow PN, Thompson JF, Tattersall MHN, Beeney LJ, Dunn SM . Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol 2003; 14: 48–56.

    Article  CAS  Google Scholar 

  6. Sardell AN, Trierweiler SJ . Disclosing the cancer diagnosis. Procedures that influence patient hopefulness. Cancer 1997; 72: 3355–3365.

    Article  Google Scholar 

  7. Ptacek JT, Eberhardt TL . The patient–physician relationship. Breaking bad news: a review of the literature. JAMA 1996; 276: 492–496.

    Article  Google Scholar 

  8. Rutter DR, Iconomou G, Quine L . Doctor–patient communication and outcome in cancer patients: an intervention. Psych Health 1996; 12: 57–71.

    Article  Google Scholar 

  9. Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P . Quality of life, taste, olfactory and oral function following high-dose of chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2002; 30: 785–792.

    Article  CAS  Google Scholar 

  10. Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngenic transplantation. Bone Marrow Transplant 2002; 30: 619–626.

    Article  CAS  Google Scholar 

  11. Caro J, Ward A, Craig Green T, Huybrechts K, Arana A, Wait S et al. Impact of Thalassemia major on patients and their families. Acta Haematol 2002; 107: 150–157.

    Article  Google Scholar 

  12. Arboretti R, Tognoni G, Alberti D . Pharmacosurveillance and quality of care of thalassaemic patients. Eur J Clin Pharmacol 2001; 56: 915–922.

    Article  CAS  Google Scholar 

  13. Hjermstad MJ, Holte H, Evensen SA, Fayers PM, Kaasa S . Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year? Bone Marrow Transplant 1999; 24: 911–918.

    Article  CAS  Google Scholar 

  14. Hjermstad MJ, Loge JH, Evensen SA, Kvaloy SO, Fayers PM, Kaasa S . The course of anxiety and depression during the first year after allogenic or autologous stem cell transplantation. Bone Marrow Transplant 1999; 24: 1219–1228.

    Article  CAS  Google Scholar 

  15. Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F et al. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant 1997; 20: 307–315.

    Article  CAS  Google Scholar 

  16. Sutherland HJ, Fyles GM, Adams G, Hao Y, Lipton JH, Minden MD et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant 1997; 19: 1129–1136.

    Article  CAS  Google Scholar 

  17. Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C et al. Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 2002; 100: 1192–1200.

    Article  CAS  Google Scholar 

  18. Beauchamp TL, Childress JF (eds). Principles of Biomedical Ethics. Oxford University Press: New York, NY, 1994, 190 pp.

    Google Scholar 

  19. Pellegrino E . Humanistic base for professional ethics in medicine. New York State J Med 1997; 77: 1456–1462.

    Google Scholar 

  20. Engel E . The clinical application of the biopsychosocial model. Am J Psychiatry 1980; 137: 535–544.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Roberto Dell'Oro, Professor of Bioethics at Loyola Marymount University in Los Angeles, for his precious comments and critical revision of the manuscript. We thank Anna Maria Koopmans for her assistance in preparing the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G Caocci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caocci, G., Pisu, S., Argiolu, F. et al. Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues. Bone Marrow Transplant 37, 165–169 (2006). https://doi.org/10.1038/sj.bmt.1705236

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705236

Keywords

This article is cited by

Search

Quick links